Fort Washington Investment Advisors Inc Novartis Ag Transaction History

Fort Washington Investment Advisors Inc

$15 Billion
Q2 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 34,625 shares of NVS stock, worth $4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

34,625

Previous 95,317 63.67%

Holding current value

$4 Million

Previous $9.22 Million 60.02%

% of portfolio

0.02%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$92.57 - $107.37 $5.62 Million - $6.52 Million	-60,692 Reduced 63.67%	34,625 $3.69 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $52,398 - $59,658	-550 Reduced 0.57%	95,317 $9.22 Million
Q4 2023 Jan 17, 2024	SELL	$92.27 - $101.54 $21,314 - $23,455	-231 Reduced 0.24%	95,867 $9.68 Million
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $102,687 - $113,960	-1,084 Reduced 1.12%	96,098 $9.79 Million
Q2 2023 Jul 28, 2023	SELL	$92.52 - $104.91 $36,637 - $41,544	-396 Reduced 0.41%	97,182 $9.81 Million
Q4 2022 Jan 30, 2023	SELL	$75.55 - $92.52 $39,437 - $48,295	-522 Reduced 0.53%	97,578 $8.85 Million
Q3 2022 Oct 26, 2022	SELL	$74.61 - $87.26 $187,569 - $219,371	-2,514 Reduced 2.5%	98,100 $7.46 Million
Q2 2022 Aug 05, 2022	SELL	$80.52 - $93.75 $197,274 - $229,687	-2,450 Reduced 2.38%	100,614 $8.51 Million
Q1 2022 May 03, 2022	SELL	$80.11 - $90.62 $8,011 - $9,062	-100 Reduced 0.1%	103,064 $9.04 Million
Q4 2021 Feb 07, 2022	SELL	$79.7 - $88.13 $411,172 - $454,662	-5,159 Reduced 4.76%	103,164 $9.02 Million
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $24,534 - $28,542	-300 Reduced 0.28%	108,323 $8.86 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $180,708 - $199,598	-2,120 Reduced 1.91%	108,623 $9.91 Million
Q1 2021 May 05, 2021	SELL	$83.5 - $98.47 $308,950 - $364,339	-3,700 Reduced 3.23%	110,743 $9.47 Million
Q4 2020 Feb 03, 2021	SELL	$78.07 - $94.43 $67,920 - $82,154	-870 Reduced 0.75%	114,443 $10.8 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $2.36 Million - $2.61 Million	-28,693 Reduced 19.92%	115,313 $10 Million
Q2 2020 Jul 31, 2020	SELL	$80.93 - $91.1 $57.1 Million - $64.3 Million	-705,355 Reduced 83.05%	144,006 $12.6 Million
Q1 2020 May 06, 2020	BUY	$70.67 - $99.01 $5.93 Million - $8.31 Million	83,921 Added 10.96%	849,361 $70 Million
Q4 2019 Feb 03, 2020	SELL	$84.35 - $95.37 $23.7 Million - $26.8 Million	-281,498 Reduced 26.89%	765,440 $72.5 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $31.7 Million - $34.9 Million	-370,777 Reduced 26.15%	1,046,938 $91 Million
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $11.7 Million - $14.4 Million	-155,136 Reduced 9.86%	1,417,715 $129 Million
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $28.1 Million - $32.1 Million	-372,968 Reduced 19.17%	1,572,851 $151 Million
Q4 2018 Feb 05, 2019	SELL	$73.66 - $82.02 $5.48 Million - $6.1 Million	-74,366 Reduced 3.68%	1,945,819 $167 Million
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $769,140 - $889,670	11,490 Added 0.57%	2,020,185 $174 Million
Q2 2018 Jul 27, 2018	BUY	$64.91 - $73.36 $14.9 Million - $16.8 Million	229,048 Added 12.87%	2,008,695 $152 Million
Q1 2018 May 02, 2018	BUY	$70.39 - $84.15 $1.06 Million - $1.27 Million	15,040 Added 0.85%	1,779,647 $144 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $6.8 Million - $7.3 Million	93,988 Added 5.63%	1,764,607 $148 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $354,537 - $369,505	4,782 Added 0.29%	1,670,619 $143 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,665,837	1,665,837 $139 Million

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Novartis Ag Transaction History